As of 9:30 AM on the 15th, Seegene is trading at 174,500 KRW, down 1.08% from the previous day. The trading volume is 51,702 shares, which is about 22.25% of the previous day's volume. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.


On February 10, Kim Choonghyun, a researcher at Mirae Asset Daewoo, stated, "Seegene fell 2.8% compared to the previous day due to disclosures regarding three issues from 2011 to the first half of 2019. While it is appropriate to be pointed out for the mistakes, additional risks are expected to be limited," and set Seegene's target price at 275,800 KRW.


Over the past five days, individual investors have net sold 63,261 shares of Seegene, while foreigners and institutions have net bought 117,427 shares and net sold 51,256 shares, respectively.



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing